• LAST PRICE
    181.0000
  • TODAY'S CHANGE (%)
    Trending Up4.3300 (2.4509%)
  • Bid / Lots
    180.7300/ 1
  • Ask / Lots
    181.2700/ 2
  • Open / Previous Close
    178.3800 / 176.6700
  • Day Range
    Low 177.1300
    High 181.2800
  • 52 Week Range
    Low 126.9450
    High 231.0000
  • Volume
    21,675
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 176.67
TimeVolumeMEDP
09:32 ET2207179.06
09:36 ET400177.74
09:38 ET100177.525
09:43 ET125177.422
09:45 ET300177.66
09:50 ET300178.53
09:52 ET400178.09
09:54 ET100178.54
09:56 ET200178.16
09:59 ET400178.54
10:03 ET200179.0967
10:06 ET600179.115
10:08 ET3929179.44
10:10 ET100179.56
10:12 ET900180.23
10:14 ET100179.85
10:15 ET267180.2175
10:17 ET400181.28
10:19 ET300181.07
10:24 ET200181
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMEDP
Medpace Holdings Inc
5.5B
31.4x
+67.16%
United StatesALKS
Alkermes Plc
4.2B
-44.1x
---
United StatesCRSP
CRISPR Therapeutics AG
6.2B
-9.9x
---
United StatesVIR
Vir Biotechnology Inc
4.1B
3.8x
---
United StatesNVAX
Novavax Inc
3.2B
-2.2x
---
United StatesIONS
Ionis Pharmaceuticals Inc
6.5B
-232.4x
---
As of 2022-08-11

Company Information

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Contact Information

Headquarters
5375 Medpace WayCINCINNATI, OH, United States 45227-1543
Phone
513-579-9911
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer
August Troendle
President, Chief Operating Officer - Laboratory Operations
Jesse Geiger
Treasurer
Kevin Brady
Executive Vice President - Operations
Susan Burwig
General Counsel, Corporate Secretary
Stephen Ewald

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.5B
Revenue (TTM)
$1.3B
Shares Outstanding
31.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.44
EPS
$5.76
Book Value
$26.47
P/E Ratio
31.4x
Price/Sales (TTM)
4.3
Price/Cash Flow (TTM)
23.7x
Operating Margin
18.11%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.